An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for BEAM THERAPEUTICS Inc
| Ticker | BEAM |
| FIGI | BBG00KXC8646 |
| CUSIP | 07373V105 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 209 / 3.0% |
| Percentage held by institutional investors | 100.0% |
About
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods. Wikipedia